Press Releases

Wednesday, January 20, 2010

BUFFALO, NY - Roswell Park Cancer Institute (RPCI) announced a grant award for $1.7M from the National Institute for Allergies and Infectious Disease to study some human therapeutics targeting acute radiation syndrome.

Wednesday, January 13, 2010

BUFFALO, NY - Roswell Park Cancer Institute (RPCI) is the recipient of a grant from Susan G. Komen for the Cure for $186,000 to support research exploring the role of certain genetic markers in the development of breast cancer.

Tuesday, January 5, 2010

BUFFALO, NY - Roswell Park Cancer Institute (RPCI) ranks in the 96th percentile nationwide for overall patient satisfaction, according to the 2009 Press, Ganey Inpatient Satisfaction Survey, which rates more than 1,000 hospitals across the country.

Wednesday, December 23, 2009

Roswell Park Cancer Institute (RPCI) announced an Institutional Research Grant (IRG) for $180,000 from the American Cancer Society to provide pilot funding for junior-level investigators.

Monday, December 21, 2009

Buffalo, NY - Most patients with anal cancer receive radiation as part of their treatment plan, but the anus is “a very sensitive area of the human body, almost like the fingertips,” notes Gary Yang, MD, Director of Gastrointestinal Radiation Medicine at Roswell Park Cancer Institute (RPCI).

Friday, December 18, 2009

Initial results from a large, randomized clinical trial for patients with multiple myeloma, a cancer of the blood and bone marrow, showed that patients who received the oral drug lenalidomide (Revlimid, also known as CC-5013) following a blood stem cell transplant had their cancer kept in check l

Tuesday, December 15, 2009

Network affiliation will produce exciting and dynamic opportunities for patients and Meadville Medical Center staff

Friday, December 11, 2009

BUFFALO, NY – Clement Ip, PhD, Professor Emeritus in Oncology from the Department of Cancer Prevention and Control at Roswell Park Cancer Institute (RPCI), is the principal investigator of a $5.4M P01 grant from the National Institutes of Health to study the role of finasteride and selenium in pr

Friday, December 11, 2009

Roswell Park Cancer Institute Produces Hip Hop Song and Video to Raise Cancer Awareness Among Generation Y

Friday, November 20, 2009

BUFFALO, NY – Roswell Park Cancer Institute (RPCI) physician Roberto Pili, MD, has been awarded an R01 grant from the National Institutes of Health to study the role of histone deacetylase (HDAC) inhibitors in treating renal cell carcinoma (RCC). The two-year grant is for $675,000.